Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 7111075Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2024
Linked Award Amount
$2M
Full award amounts, FY2024
Award Records
2
Records listing this PI
Award-Linked Rank
#5,368
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Xinmin Simon Xie as a PI. Multi-PI records show the full award amount for context.
- 5R44NS132642-02R44Clinical Phase I trials on an IND single molecule dual inhibitor of Cav3 channels and soluble epoxide hydrolase for treatment of neuropathic pain$1.5Maward amount
- 5U43AA031391-02U43Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase$498.9Kaward amount
Award organization
Organizations that administered FY2024 awards listing Xinmin Simon Xie as a PI.
FY2024 award administered by Afasci, Inc. (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardAfasci, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5368
- 2025$2M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Xinmin Simon Xie.